CERO today
$0.01+$0.00 (+23.46%)close Jun 25, 2026Trend
—
Key levels
—
Latest news & SEC filings
ProductCERo Therapeutics doses seventh patient in Phase 1 trial of CER-1236
NewsCERo Therapeutics opens UC Davis site for clinical trial and manufacturing
ProductCERo Therapeutics activates another site for CERTAIN-T clinical trial
All CERO news →OTC · Healthcare
CERO THERAPEUTICS HOLDINGS, INC. (CERO)
What Is the Price Target for CERO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is CERO a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CERO.
Start Free Trial →Is CERO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
PEG
Fair Value
$9.36
5
Moat Score
NONE
2/9
Piotroski Score
-43.9
Altman Z-Score
What Is Smart Money Doing with CERO?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CERO Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CERO THERAPEUTICS HOLDINGS, INC. (CERO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CERO — frequently asked questions
What is CERO stock price today?
CERO THERAPEUTICS HOLDINGS, INC. (CERO) is at $0.01, up 23.46% (+$0.00) at the Jun 25, 2026 close.
Why is CERO stock moving today?
Latest CERO news — Nov 3, 2026: CERo Therapeutics doses seventh patient in Phase 1 trial of CER-1236 · Oct 28, 2026: CERo Therapeutics opens UC Davis site for clinical trial and manufacturing
Did CERO beat earnings?
CERO last reported on Aug 14, 2026: EPS -$0.54 vs -$0.80 expected — a beat of 32.1%.
Does CERO pay a dividend?
CERO does not currently pay a dividend.
What are insiders doing with CERO?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on CERO?
Nov 3, 2026: CERo Therapeutics doses seventh patient in Phase 1 trial of CER-1236 · Oct 28, 2026: CERo Therapeutics opens UC Davis site for clinical trial and manufacturing · Oct 26, 2026: CERo Therapeutics activates another site for CERTAIN-T clinical trial